This study examined the potential interaction between genetic risk and severe COVID-19 in patients with and without COPD using data from 430,582 participants in the UK Biobank study. Identification of patients with COPD was achieved using spirometry, self-reported diagnoses, and diagnostic codes. Spirometry was performed using a Vitalograph Pneumotrac device.
- Author Huang QM et al.
- Publication Annals of the American Thoracic Society
- Year 2021
- Device Type Pneumotrac, Spirotrac